Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly once versus thrice-weekly rhEPO in maintenance hemodialysis renal anemia
ChiCTR1900022471Phase 4Recruiting
- Sponsor
- First Hospital of China Medical University
- Start
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of erythropoietin in anemia of chronic kidney disease (2 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Hemoglobin concentration. Started Jan 2019; status: recruiting.
02
Drugs
erythropoietin
03
Conditions
anemia of chronic kidney disease
Beyond the preview
Go deeper on ChiCTR1900022471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900022471.